bortezomib 3.5 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
velcade 3.5mg powder for solution for injection vials
janssen-cilag ltd - bortezomib - powder for solution for injection - 3.5mg
ambisome liposomal 50mg powder for dispersion for infusion vials
gilead sciences ltd - amphotericin b liposomal - powder for dispersion for infusion - 50mg
bortezomib medac 3.5 mg powder for solution for injection
medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib rowex 3.5 mg powder for solution for injection
rowex ltd - bortezomib (as mannitol boronic ester) - powder for solution for injection - 3.5 milligram(s) - bortezomib
bortezomib teva 2.5mg powder for solution for injection
teva b.v. - bortezomib - powder for solution for injection - 2.5 milligram(s) - bortezomib
bortezomib 2.5 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 2.5 milligram(s) - bortezomib
dynastat parecoxib (as sodium) 40mg powder for injection vial
pfizer australia pty ltd - parecoxib sodium, quantity: 42.36 mg (equivalent: parecoxib, qty 40 mg) - injection, powder for - excipient ingredients: sodium hydroxide; phosphoric acid; dibasic sodium phosphate - for a single peri-operative dose for the management of post-operative pain.
amitriptyline hydrochloride 10mg/5ml oral solution
syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 10 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline
amitriptyline hydrochloride 25mg/5ml oral solution
syri pharma limited t/a thame laboratories - amitriptyline hydrochloride - oral solution - 25 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline